IGF2R and obesity due to melanocortin 4 receptor deficiency: MiR-143-3p silencing participates in the development of obesity-mediated insulin resistance, glucose tolerance and lipid accumulation and characterizes the miR-143-3p-IGF2R cascade as a possible target of treating obesity-linked metabolic diseases (Xihua et al., 2019).